Nicolas Leupin
Technik-/Wissenschafts-/F&E-Leiter bei NOVOCURE LIMITED
Vermögen: 729 878 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Nicolas Leupin
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Medical Specialties | 20 | |
Public Company | Biotechnology | 18 | |
10
| Public Company | Pharmaceuticals: Other | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nicolas Leupin
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal President Chief Tech/Sci/R&D Officer Human Resources Officer | |
SURFACE ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
NovoCure GmbH
NovoCure GmbH Pharmaceuticals: MajorHealth Technology Part of NovoCure Ltd., NovoCure GmbH is a German company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The company is based in Munich, Germany. The CEOs of the company are Asaf Danziger, Wilhelmus C. M. Groenhuysen. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
Jazz Pharmaceuticals UK Ltd.
Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
OPTINOSE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Bern | College/University | Doctorate Degree Masters Business Admin | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
INTERSECT ENT, INC. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin | |
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NUVATION BIO INC. | Biotechnology | Founder Director/Board Member | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Director/Board Member | |
SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NYKODE THERAPEUTICS | Pharmaceuticals: Major | Founder | |
Cybro Medical Ltd. | Chief Executive Officer | ||
Israel Defense Forces | Sovereign | Corporate Officer/Principal | |
University of Oslo | College/University | Doctorate Degree | |
Revitas, Inc.
Revitas, Inc. Packaged SoftwareTechnology Services Revitas, Inc. engages in the delivering integrated solutions for contract, revenue and compliance management. The company was founded in 1989 and is headquartered in Philadelphia, PA. | Packaged Software | Director/Board Member | |
Ben-Gurion University of the Negev | College/University | Undergraduate Degree | |
Washington University School of Medicine | College/University | Doctorate Degree | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
The California State University | College/University | Doctorate Degree | |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Investor Relations Contact | |
Amgen Ventures LLC
Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Corporate Officer/Principal | |
Grandeco Wallfashion Group Belgium NV
Grandeco Wallfashion Group Belgium NV Home FurnishingsConsumer Durables Grandeco Wallfashion Group-Belgium NV engages in the design and manufacture of wallpapers. Its brands include Wall Fashion, Grandeco Boutique, Deco4Walls, Grandeco Life, and VerticalArt. The company was founded in 1978 and is headquartered in Tielt, Belgium. | Home Furnishings | Director/Board Member | |
TINC Manager NV
TINC Manager NV Financial ConglomeratesFinance Part of TDP NV, TINC Manager NV is an investment holding Belgian company. The company is based in Antwerp, Belgium. Founded in 2014, TINC Manager functions as an investment holding company. | Financial Conglomerates | Director/Board Member | |
TINC N.V. | Investment Managers | Director/Board Member | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
GIMV NV | Investment Managers | Corporate Secretary | |
Ghent University | College/University | Graduate Degree | |
MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 27 |
Belgien | 7 |
Israel | 6 |
Vereinigtes Königreich | 5 |
Schweiz | 4 |
Sektoral
Health Technology | 29 |
Consumer Services | 10 |
Finance | 7 |
Distribution Services | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 233 |
Corporate Officer/Principal | 86 |
Independent Dir/Board Member | 79 |
Undergraduate Degree | 30 |
Chairman | 27 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Göran Albert Ando | 44 |
Bill Doyle | 38 |
Tony Vernon | 34 |
Petri T. Vainio | 24 |
David Hung | 24 |
Anthony Adam Rosenberg | 23 |
John Paul de Koning | 21 |
Sandipkumar S. Kapadia | 19 |
Pamela Klein | 19 |
Jeryl Hilleman | 19 |
Michael Vasconcelles | 17 |
Timothy Scannell | 14 |
Andreas Emmenegger | 14 |
James Daly | 13 |
Kin Yip Leung | 11 |
- Börse
- Insiders
- Nicolas Leupin
- Unternehmensverbindungen